A phase III randomised trial of cisplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck. Liverpool Head and Neck Oncology Group.
暂无分享,去创建一个
M. Gerretsen | G. Snow | G. V. van Dongen | C. Meijer | The Nagasaki Thoracic Oncology Group | J. J. Quakl | J. Suhl | M. Van Walsuml | M Correspondence | Gerretsen
[1] D. Hedley. Flow cytometry using paraffin-embedded tissue: five years on. , 1989, Cytometry.
[2] J. Brierley. Classification of Malignant Tumours , 1963, British medical journal.
[3] L L Vindeløv,et al. A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis. , 1990, Cytometry.
[4] W. McGuire,et al. Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors , 1990, Cancer.
[5] D. Haines,et al. A novel marker for basal (stem) cells of mammalian stratified squamous epithelia and squamous cell carcinomas. , 1989, Cancer research.
[6] F. Muggia,et al. Role of chemotherapy in head and neck cancer: systemic use of single agents and combinations in advanced disease. , 1980, Head & Neck Surgery.
[7] D. Spandidos,et al. Clinical relevance of oncogene expression in head and neck tumours. , 1986, Anticancer research.
[8] P. Bunn,et al. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. , 1984, Journal of immunological methods.
[9] O. Mjølnerød,et al. DNA‐ploidy as prognostic factor in prostatic carcinoma , 1990, International journal of cancer.
[10] W. Fee,et al. Reactivity of monoclonal antibody 17.13. with human squamous cell carcinoma and its application to tumor diagnosis. , 1987, Cancer research.
[11] A. Wein,et al. Simultaneous flow cytometric deoxyribonucleic acid and acid phosphatase analysis of benign and malignant lesions of the prostate. , 1985, The Journal of urology.
[12] L. Layfield,et al. Relationship of DNA content to conventional prognostic factors in clinically localised carcinoma of the prostate. , 1988, British journal of urology.
[13] I. Christensen,et al. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. , 1983, Cytometry.
[14] M. Herlyn,et al. Development of monoclonal antibodies that recognize antigens associated with human cervical carcinoma. , 1986, Acta cytologica.
[15] J. Bulte,et al. Monoclonal antibody JSB‐1 detects a highly conserved epitope on the P‐glycoprotein associated with multi‐drug‐resistance , 1988, International journal of cancer.
[16] M. Namba,et al. Monoclonal antibodies against human oral squamous cell carcinoma reacting with keratin proteins , 1987, Cancer.
[17] F. Askin,et al. Significance of ploidy in laryngeal cancer. , 1986, American journal of surgery.
[18] J. Jacobs,et al. A randomized trial of cisplatin (CACP) + 5‐fluorouracil (5‐FU) infusion and CACP + 5‐FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck , 1985, Cancer.
[19] G. Murphy,et al. LNCaP model of human prostatic carcinoma. , 1983, Cancer research.
[20] T. Therneau,et al. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis. , 1989, Mayo Clinic proceedings.
[21] E. Haber,et al. Immunogenicity and kinetics of distribution and elimination of sheep digoxin-specific IgG and Fab fragments in the rabbit and baboon. , 1979, Clinical and experimental immunology.
[22] J. Wilson,et al. Factors predicting response of end stage squamous cell carcinoma of the head and neck to cisplatinum. , 1987, Clinical otolaryngology and allied sciences.
[23] B. Brenner,et al. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation. , 1982, Cancer research.
[24] R. Vessella,et al. Correlation of vascular permeability and blood flow with monoclonal antibody uptake by human Clouser and renal cell xenografts. , 1988, Cancer research.
[25] N. Jambhekar,et al. Monoclonal antibody against human squamous‐cell‐carcinoma‐associated antigen , 1989, International journal of cancer.
[26] F. Habib,et al. Nuclear DNA analysis of prostate tissues: correlation with stage and grade of tumour. , 1989, Urologia internationalis.
[27] W. Dixon,et al. BMDP statistical software , 1983 .
[28] M. Gerretsen,et al. Detection of squamous cell carcinoma xenografts in nude mice by radiolabeled monoclonal antibody E48. , 1991, Archives of otolaryngology--head & neck surgery.
[29] I. Bernstein,et al. In vitro measurement of avidity of radioiodinated antibodies. , 1987, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.
[30] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[31] R. Wahl,et al. Improved radioimaging and tumor localization with monoclonal F(ab')2. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[32] T. Therneau,et al. Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry. , 1988, Mayo Clinic proceedings.
[33] O. Kallioniemi. Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity. , 1988, Cytometry.
[34] T. Koyanagi,et al. Establishment of Monoclonal Antibody to Human Androgen Receptor and Its Clinical Application for Prostatic Cancers , 1988, American journal of clinical oncology.
[35] S. Jones,et al. Monoclonal antibodies to human squamous cell carcinoma of the lung and their application to tumor diagnosis. , 1985, Cancer research.
[36] J. Adolfsson,et al. The prognostic value of modal deoxyribonucleic acid in low grade, low stage untreated prostate cancer. , 1990, The Journal of urology.
[37] P. Bradley,et al. Induction VBM plus radiotherapy, versus radiotherapy alone for advanced head and neck cancer: long-term results. , 1989, Clinical otolaryngology and allied sciences.
[38] A. Miller,et al. Reporting results of cancer treatment , 1981, Cancer.
[39] D. Schwartz,et al. Antibodies to human squamous cell carcinoma , 1983, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[40] J. Jett,et al. MATHEMATICAL ANALYSIS OF DNA DISTRIBUTIONS DERIVED FROM FLOW MICROFLUOROMETRY , 1974, The Journal of cell biology.
[41] R. E. Cunningham,et al. Prognostic significance of DNA ploidy in carcinoma of prostate. , 1989, Urology.
[42] J. Isaacs,et al. Biology and therapy of prostatic cancer. , 1986, Cancer surveys.
[43] W. Greco,et al. Proliferative characteristics of primary and metastatic human solid tumors by DNA flow cytometry. , 1984, Cytometry.
[44] V. Zurawski,et al. Iodination of monoclonal antibodies for diagnosis and radiotherapy using a convenient one vial method. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[45] G. Snow,et al. A 22-kd surface antigen detected by monoclonal antibody E 48 is exclusively expressed in stratified squamous and transitional epithelia. , 1990, The American journal of pathology.
[46] T. Carey,et al. Altered expression in squamous carcinoma cells of an orientation restricted epithelial antigen detected by monoclonal antibody A9. , 1986, Cancer research.
[47] P. Humphrey,et al. Comparative localization of murine monoclonal antibody Me1-14 F(ab')2 fragment and whole IgG2a in human glioma xenografts. , 1988, Cancer research.
[48] P. Okunieff,et al. Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. , 1989, Cancer research.
[49] D. Paulson,et al. Flow cytometric determination of ploidy in prostatic adenocarcinoma: a comparison with seminal vesicle involvement and histopathological grading as a predictor of clinical recurrence. , 1988, The Journal of urology.
[50] R. Gelber,et al. Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer. , 1987, Cancer research.
[51] M. Melamed,et al. Flow cytometry of prostate cancer: relationship of DNA content to survival. , 1987, Cancer research.
[52] I W Taylor,et al. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. , 1983, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[53] J. Dodd,et al. Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines. , 1990, The Journal of urology.
[54] G. Snow,et al. Localization and imaging of radiolabelled monoclonal antibody against squamous‐cell carcinoma of the head and neck in tumor‐bearing nude mice , 1989, International journal of cancer.
[55] T. Visakorpi,et al. Improved prognostic impact of S-phase values from paraffin-embedded breast and prostate carcinomas after correcting for nuclear slicing. , 1991, Cytometry.
[56] J. Bertino,et al. The role of chemotherapy in the management of cancer of the head and neck: A review , 1975, Cancer.
[57] R. Reisfeld,et al. Antigens associated with human squamous cell lung carcinoma defined by murine monoclonal antibodies. , 1986, Cancer research.
[58] Robert W. McDivitt,et al. A proposed classification of breast cancer based on kinetic information derived from a comparison of risk factors in 168 primary operable breast cancers , 1986, Cancer.
[59] G. Williams,et al. Prostatic carcinoma cell DNA content measured by flow cytometry and its relation to clinical outcome , 1986, The British journal of surgery.
[60] D. Karnofsky. The clinical evaluation of chemotherapeutic agents in cancer , 1949 .
[61] D.,et al. Regression Models and Life-Tables , 2022 .
[62] J. Jacobs,et al. Squamous Cell Carcinoma of the Head and Neck , 2006 .
[63] E. Thonar,et al. Biochemical studies of the matrix of craniovertebral chordoma and a metastasis , 1979, Cancer.
[64] S. Vogl,et al. Chemotherapy of advanced head and neck cancer with methotrexate, bleomycin, and cis‐diamminedichloroplatinum II in an effective outpatient schedule , 1979, Cancer.
[65] W. Mooi,et al. Localization of monoclonal antibody auai and its F(ab')2 fragments in human tumour xenografts: An autoradiographic and immunohistochemical study , 1988, International journal of cancer. Supplement = Journal international du cancer. Supplement.